These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31103378)

  • 1. Meningococcal Vaccination Among Adolescents in the United States: A Tale of Two Age Platforms.
    Kurosky SK; Esterberg E; Irwin DE; Trantham L; Packnett E; Novy P; Whelan J; Hogea C
    J Adolesc Health; 2019 Jul; 65(1):107-115. PubMed ID: 31103378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.
    Mbaeyi S; Pondo T; Blain A; Yankey D; Potts C; Cohn A; Hariri S; Shang N; MacNeil JR
    JAMA Pediatr; 2020 Sep; 174(9):843-851. PubMed ID: 32687590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.
    Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS
    J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
    Baxter R; Reisinger K; Block SL; Izu A; Odrljin T; Dull P
    J Pediatr; 2014 Jun; 164(6):1409-15.e4. PubMed ID: 24657122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
    Abdelnour A; Silas PE; Lamas MR; Aragón CF; Chiu NC; Chiu CH; Acuña TH; Castrejón Tde L; Izu A; Odrljin T; Smolenov I; Hohenboken M; Dull PM
    Vaccine; 2014 Feb; 32(8):965-72. PubMed ID: 24397906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(34):685-93. PubMed ID: 23985496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Meningococcal ACWY vaccination in adolescents in the US: completion and compliance with the CDC recommendations.
    Cheng WY; Chang R; Novy P; O'Connor C; Duh MS; Hogea CS
    Hum Vaccin Immunother; 2020; 16(1):176-188. PubMed ID: 31419168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger EC; Meyer S; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(2):105-14. PubMed ID: 25483566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM;
    Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant HPV and MenACWY vaccination among sixth and seventh graders receiving Tdap.
    Doke K; Fitzgerald SA; Barral RL; Griffin P; Ellerbeck EF
    Vaccine; 2018 Oct; 36(45):6819-6825. PubMed ID: 30266487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
    Jonker EFF; van Ravenhorst MB; Berbers GAM; Visser LG
    Vaccine; 2018 Jun; 36(26):3727-3732. PubMed ID: 29778515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.
    Vesikari T; Borrow R; Da Costa X; Thomas S; Eymin C; Boisnard F; Lockhart S
    Vaccine; 2018 Dec; 36(52):8019-8027. PubMed ID: 30471953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
    Ghaswalla PK; Bengtson LGS; Marshall GS; Buikema AR; Bancroft T; Schladweiler KM; Koep E; Novy P; Hogea CS
    Vaccine; 2021 Jan; 39(2):272-281. PubMed ID: 33309081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cohn AC; MacNeil JR; Clark TA; Ortega-Sanchez IR; Briere EZ; Meissner HC; Baker CJ; Messonnier NE;
    MMWR Recomm Rep; 2013 Mar; 62(RR-2):1-28. PubMed ID: 23515099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.
    Hansen J; Zhang L; Klein NP; Robertson CA; Decker MD; Greenberg DP; Bassily E; Baxter R
    Vaccine; 2017 Dec; 35(49 Pt B):6879-6884. PubMed ID: 28941623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.
    Quiambao BP; Jain H; Bavdekar A; Dubey AP; Kolhe D; Bianco V; Van der Wielen M; Miller JM
    Hum Vaccin Immunother; 2016 Aug; 12(8):2162-2168. PubMed ID: 27152501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missed opportunities for adolescent vaccination, 2006-2011.
    Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
    J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.
    Broderick MP; Romero-Steiner S; Rajam G; Johnson SE; Milton A; Kim E; Choi LJ; Radin JM; Schmidt DS; Carlone GM; Messonnier N; Faix DJ
    Clin Vaccine Immunol; 2016 Aug; 23(8):672-80. PubMed ID: 27280619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.